WATCH NOW
Lexeo Therapeutics Webinar | September 2024
On September 24, 2024, Lexeo Therapeutics Vice President, Clinical Development, Cardiology Franca S. Angeli, MD, PhD, provided an overview of LX2006 and details about their phase1/2 clinical trial to study the safety and efficacy of LX2006. The full recording is available for viewing.
